Sponsored by
This free webinar will take place on Thursday, May 21, 2026 at 6pm ET and will feature Dr. Matt Williams discussing the combination of temozolomide and lomustine for glioblastoma (GBM), including background from the NOA-09 trial in MGMT-methylated GBM, new insights from a UK real-world dataset, and future plans for generating additional evidence. The talk will be followed by a Q&A session. You can pre-register for the event HERE.